P
Chromocell Therapeutics (PTHS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Chromocell Therapeutics (PTHS)
Chromocell Therapeutics Corporation is a clinical-stage biotech company, which is focused on developing and commercializing therapeutics to alleviate pain. The Company's clinical focus is to selectively target the sodium ion-channel, NaV1.7, as well ... Read more
- USD21.13
- USD22.70
- USD19.89
- USD54.29
- 65.40%
- --
- 30.69k
- 115.44k
- 56M
- 4.50
- 69.50%
Stock News
5 hours ago
Trump sent Jeffrey Epstein 'bawdy' 50th birthday letter: WSJ
CNBC
yesterday
Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'
CNBC
yesterday
Fed’s Waller says labor market is weaker than it looks, justifying interest-rate cut this month
MarketWatch
yesterday
Rocket Companies to Announce Second Quarter 2025 Results on July 31, 2025
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
